Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07860242 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combined Rhodiola Rosea and Caffeine Supplementation for Aerobic Gymnastics Performance

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Aerobic gymnastics requires repeated explosive movements, upper-body support elements, and the ability to maintain performance under fatigue. This randomized, double-blind, placebo-controlled trial evaluates the effects of Rhodiola rosea supplementation, acute caffeine ingestion, and their combination on sport-specific performance and recovery in female competitive aerobic gymnasts. Ninety-six female aerobic gymnasts will be randomly assigned to placebo, Rhodiola rosea, caffeine, or combined Rhodiola rosea plus caffeine groups. All participants will complete an 8-week standardized aerobic gymnastics training program. Rhodiola rosea will be supplemented daily during the intervention period, while caffeine or matched placebo will be administered before post-intervention performance testing. The primary outcome is the change in Specific Aerobic Gymnastics Anaerobic Test (SAGAT) total completion time. Secondary outcomes include neuromuscular performance, fatigue-related responses, perceived exertion, muscle soreness, and perceived recovery status.
Trial Details
NCT Number NCT07860242
Lead Sponsor Beijing Sport University
Collaborators: Wuhan Sports University, Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences
Conditions
(from sponsor)
Aerobic Gymnastics Performance, Sports Performance, Exercise Recovery, Nutritional Supplementation
Enrollment 96 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov